Suppr超能文献

异常隐窝病灶

Aberrant crypt foci.

作者信息

Alrawi Sadir J, Schiff Michael, Carroll Robert E, Dayton Merril, Gibbs John F, Kulavlat Mahmood, Tan Dongfeng, Berman Kevin, Stoler Daniel L, Anderson Garth R

机构信息

Division of Gastrointestinal Surgery, Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

出版信息

Anticancer Res. 2006 Jan-Feb;26(1A):107-19.

Abstract

Colon cancer evolves through epithelial cell deregulation and inappropriate proliferation. These histopathological characteristics are exemplified in the biochemical, immunohistochemical, genetic and epigenetic elements detected within colonic mucosa. Early detection is paramount for the prevention of colon cancer deaths. Aberrant crypt foci (ACF) are thought to be the earliest identifiable neoplastic lesions in the colon carcinogenetic model. The progression of ACF to polyp and, subsequently, to cancer parallels the accumulation of several biochemical alterations and mutations whereby a small fraction of ACF evolve to colon cancer. Recent data indicate that, not uncommonly, some ACF bypass the polyp stage in their carcinogenesis thus reinforcing the importance of their early detection and our understanding of their pathogenesis. Since ACF were first detected in carcinogen-treated mice, research efforts have focused on these microscopically visible lesions both in animal and human models. ACF show variable histological features, characterized by Kudo (20) and, therefore, can be grouped into differing categories by in vivo examination with high-magnification-chromoscopic-colonoscopy (HMCC). As expected, ACF are more frequently detected in distal animal and human colons coinciding with the geographic distribution of colorectal cancer (CRC). Various proteomic (Prot) markers may be altered within ACF suggesting possible prospective pathological changes. These markers include Calreticulin, Transgelin, Serotransferrin, Triphosphate isomerase and Carbonic anhydrase II. Other markers of importance include carcinoembryonic antigen (CEA), B-catenin, placental cadherin (P-cadherin), epithelial cadherin (E-cadherin), inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2) and P16INK4a. Genetic mutations of K-ras, B-Raf APC and p53 have been demonstrated in ACF as well as the epigenetic alterations of CpG island methylation. Genomic instabilities (GI), illustrated by a higher GI Index (GII), microsatellite instability (MSI), loss of heterozygosity (LOH) and defects in mismatch repair (MMR) systems, are also expressed. These transformations may lead to the identification of the earliest pathological features initiating colon tumorigenesis. In this review, the advances in ACF research as precursors of CRCs are highlighted.

摘要

结肠癌通过上皮细胞失调和异常增殖而演变。这些组织病理学特征在结肠黏膜中检测到的生化、免疫组化、遗传和表观遗传因素中得到体现。早期检测对于预防结肠癌死亡至关重要。异常隐窝灶(ACF)被认为是结肠癌发生模型中最早可识别的肿瘤性病变。ACF发展为息肉,随后发展为癌症,这与多种生化改变和突变的积累平行,其中一小部分ACF演变为结肠癌。最近的数据表明,在其致癌过程中,一些ACF常常绕过息肉阶段,从而强化了早期检测它们的重要性以及我们对其发病机制的理解。自从在致癌物处理的小鼠中首次检测到ACF以来,研究工作一直聚焦于动物和人类模型中的这些显微镜下可见的病变。ACF表现出可变的组织学特征,由工藤(20)描述,因此可以通过高倍放大染色结肠镜检查(HMCC)在体内检查将其分为不同类别。正如预期的那样,ACF在远端动物和人类结肠中更频繁地被检测到,这与结直肠癌(CRC)的地理分布一致。各种蛋白质组学(Prot)标志物可能在ACF中发生改变,提示可能存在前瞻性的病理变化。这些标志物包括钙网蛋白、转胶蛋白、血清转铁蛋白、磷酸丙糖异构酶和碳酸酐酶II。其他重要的标志物包括癌胚抗原(CEA)、β-连环蛋白、胎盘钙黏蛋白(P-钙黏蛋白)、上皮钙黏蛋白(E-钙黏蛋白)、诱导型一氧化氮合酶(iNOS)、环氧化酶(COX-2)和P16INK4a。在ACF中已证实存在K-ras、B-Raf、APC和p53的基因突变以及CpG岛甲基化的表观遗传改变。基因组不稳定性(GI),以更高的GI指数(GII)、微卫星不稳定性(MSI)、杂合性缺失(LOH)和错配修复(MMR)系统缺陷为特征,也有表现。这些转变可能导致识别启动结肠肿瘤发生的最早病理特征。在本综述中,突出了ACF作为CRC前体的研究进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验